At the Digital Medicine Connect in Boston this week, presenters wrestled with the question of what it would take to spur wider adoption of digital therapies. With Omada CEO Sean Duffy on the panel, it’s not surprising that one common answer — more and better efficacy data — came up.

Read the source article at MobiHealthNews